Purdue Pharma, Opioid epidemic

Sacklers, Purdue Pharma reach $7.4 billion settlement in opioid lawsuits
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.
The latest on the Purdue Pharma and Sackler family opioid settlement
A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack.
Purdue Pharma owners strike new $6.5 billion deal in opioid case
The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.
Sackler, Purdue Pharma $7 Billion Lawsuit: Who's Entitled to Payment
The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma, over their actions leading up to the opioid crisis, which has killed several hundreds of thousands of people in the last two decades.
Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin
The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was rejected by the Supreme Court.
Sackler family, Purdue Pharma reach $7.4 billion settlement with 15 states over opioid crisis
The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, New York Attorney General Letitia James announced Thursday.
Attorney General Raoul Helps Secure $7.5 Billion From Purdue Pharma And The Sackler Family For Fueling Opioid Crisis
CHICAGO - Attorney General Kwame Raoul, along with a bipartisan coalition of states and other parties, today announced a $7.4 billion settlement in principle
Pennsylvania to get $212 million from opioids settlement with Purdue Pharma, Sackler family
Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and the Sackler family, its owners, for their roles in the opioid overdose crisis.
Utah expected to join at least a dozen states in Purdue Pharma settlement
Utah will receive $57 million to combat the state’s opioid crisis if it joins the $7.4 billion settlement against the Sackler family and their former company, Purdue Pharma, the makers of OxyContin. The Utah Attorney General’s Office and Utah’s Department of Commerce Division of Consumer Protection said they expect to join the settlement in a
Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin
Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller.
Bankrupt Purdue buys time to advance $7.4 billion opioid deal
Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the company's years-long effort to resolve thousands of lawsuits over its addictive pain medication OxyContin.
TwinCities.com6d
Purdue Pharma owners could pay $7.4 billion in…
Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, New York ...
MTPR1d
Montana expected to receive $16.5 million from Purdue Pharma opioid settlement
Montana will sign onto a proposed national settlement with Purdue Pharma and its owners, the Sackler family, for their role in sparking the opioid crisis.